Report Code : CVMI24071651 | Published Date : July 16, 2024
The Dry Eye Disease Market is witnessing significant growth, driven by increasing screen time, a rising prevalence of ocular surface disorders, and advancements in ophthalmic treatments. Valued at USD XX billion in 2023, the market is projected to grow at a CAGR of XX% from 2024 to 2031, reaching USD XX billion by 2031.
Key Market Insights
Dry eye disease, which results from tear film instability, environmental factors, and autoimmune conditions, affects millions worldwide. The demand for advanced artificial tears, prescription medications, and innovative ophthalmic devices is increasing rapidly.
Growth Drivers
- Rising Digital Screen Usage and Eye Strain Issues – Increased exposure to computers, smartphones, and devices that emit blue light worsens dry eye symptoms.
- Advancements in Ophthalmic Therapies and Drug Formulations: The development of lipid-based artificial tears, anti-inflammatory eye drops, and regenerative medicine-based treatments is enhancing patient outcomes outcomes.
- Growing Awareness of Eye Health and Preventive Care – Eye care awareness programs and an increase in routine ophthalmic checkups are boosting the market growth.
- Expansion of Minimally Invasive Eye Treatment Technologies – The use of punctal plugs, meibomian gland therapy, and laser-based eye hydration techniques is increasing rise.
Regional Trends
- North America leads because of high screen exposure and strong adoption of prescription dry eye treatments treatments.
- Europe is witnessing an expansion in innovative eye care product launches and government-supported eye health initiatives initiatives.
- The Asia-Pacific region is experiencing rapid growth, fueled by a rise in digital eye strain cases and advancements in ophthalmic healthcare infrastructure.
- Latin America and MEA are emerging markets that benefit from increasing eye care awareness and improved healthcare accessibility.
ClearView Market Insights Analysis;
The Dry Eye Disease Market is poised for ongoing growth, propelled by technological advancements, heightened awareness of eye health, and novel treatment solutions. Companies investing in smart eye drops, AI-driven ophthalmic diagnostics, and regenerative eye care therapies will lead this evolving sector.
Reasons To Buy
nan
Scope
nan
Key Players
- Allergan plc (now part of AbbVie Inc.)
- Novartis AG
- Santen Pharmaceutical Co.
- Ltd.
- Johnson & Johnson Vision
- Bausch Health Companies Inc.
Global Dry Eye Disease Market Report
- 1. Global Dry Eye Disease Market Research Report
- 1.1 Study Objectives
- 1.2 Global Dry Eye Disease Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Dry Eye Disease Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type
- 2.1.2 By Treatment
- 2.1.3 By End User
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type, By Treatment, By End User, By Country
- 3.3. Opportunities – By Type, By Treatment, By End User, By Country
- 3.4. Trends – By Type, By Treatment, By End User, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Dry Eye Disease Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Aqueous Deficient Dry Eye
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Evaporative Dry Eye
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Pharmaceutical Products
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Over-the-Counter (OTC) Products
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Medical Devices
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Surgical Interventions
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Homecare Settings
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Specialty Clinics
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Ambulatory Surgical Centers
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.6 Global Dry Eye Disease Market - Opportunity Analysis Index, By Type, By Treatment, By End User, and Region, 2024 - 2031
- 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Aqueous Deficient Dry Eye
- 9.1.2 Evaporative Dry Eye
- 9.2.1 Pharmaceutical Products
- 9.2.2 Over-the-Counter (OTC) Products
- 9.2.3 Medical Devices
- 9.2.4 Surgical Interventions
- 9.3.1 Hospitals
- 9.3.2 Homecare Settings
- 9.3.3 Specialty Clinics
- 9.3.4 Ambulatory Surgical Centers
- 9.4.1 United States
- 9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Dry Eye Disease Market Research Report - Company Profiles- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Aqueous Deficient Dry Eye
- 10.1.2 Evaporative Dry Eye
- 10.2.1 Pharmaceutical Products
- 10.2.2 Over-the-Counter (OTC) Products
- 10.2.3 Medical Devices
- 10.2.4 Surgical Interventions
- 10.3.1 Hospitals
- 10.3.2 Homecare Settings
- 10.3.3 Specialty Clinics
- 10.3.4 Ambulatory Surgical Centers
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands
- 10.4.8 Poland
- 10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Dry Eye Disease Market Research Report - Company Profiles- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Aqueous Deficient Dry Eye
- 11.1.2 Evaporative Dry Eye
- 11.2.1 Pharmaceutical Products
- 11.2.2 Over-the-Counter (OTC) Products
- 11.2.3 Medical Devices
- 11.2.4 Surgical Interventions
- 11.3.1 Hospitals
- 11.3.2 Homecare Settings
- 11.3.3 Specialty Clinics
- 11.3.4 Ambulatory Surgical Centers
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & NZ
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Dry Eye Disease Market Research Report - Company Profiles- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Aqueous Deficient Dry Eye
- 12.1.2 Evaporative Dry Eye
- 12.2.1 Pharmaceutical Products
- 12.2.2 Over-the-Counter (OTC) Products
- 12.2.3 Medical Devices
- 12.2.4 Surgical Interventions
- 12.3.1 Hospitals
- 12.3.2 Homecare Settings
- 12.3.3 Specialty Clinics
- 12.3.4 Ambulatory Surgical Centers
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Dry Eye Disease Market Research Report - Company Profiles- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Aqueous Deficient Dry Eye
- 13.1.2 Evaporative Dry Eye
- 13.2.1 Pharmaceutical Products
- 13.2.2 Over-the-Counter (OTC) Products
- 13.2.3 Medical Devices
- 13.2.4 Surgical Interventions
- 13.3.1 Hospitals
- 13.3.2 Homecare Settings
- 13.3.3 Specialty Clinics
- 13.3.4 Ambulatory Surgical Centers
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Dry Eye Disease Market Research Report - Company Profiles- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 14.2.1 Allergan plc (now part of AbbVie Inc.)
- 14.2.2 Novartis AG
- 14.2.3 Santen Pharmaceutical Co.
- 14.2.4 Ltd.
- 14.2.5 Johnson & Johnson Vision
- 14.2.6 Bausch Health Companies Inc.
16. Principal Presumptions and Acronyms